Prognostic Significance of Tumor-associated Macrophages in Breast Cancer: a Meta-analysis of the Literature

Overview

Journal Oncotarget

Specialty Oncology

Date 2017 Apr 22

PMID 28427165

Citations 189

Authors

Xixi Zhao

Jingkun Qu

Yuchen Sun

Jizhao Wang

Xu Liu

Feidi Wang

Hong Zhang

Wen Wang

Xingcong Ma

Xiaoyan Gao

Shuqun Zhang

Affiliations

Soon will be listed here.

Abstract

Purpose: Tumor associated macrophages (TAMs) are important prognostic factors and have been proved to be associated with the invasion and migration of various cancer. However, the relationship between TAMs and breast cancer outcomes remains unclear.

Experimental Design: Sixteen studies with a total of 4,541 breast cancer patients were included in this meta-analysis. Correlation of TAMs with overall survival (OS), disease-free survival(DFS), relapse-free survival (RFS), breast cancer special survival (BCSS) and clinicopathological features were analyzed. Survival data and clinicopathological value were integrated by analyzing hazard ratio(HR) and odds ratio(OR) separately and using Fixed-effect or Random-effect model according to heterogeneity. All statistical tests were two-sided.

Results: OS and DFS were correlated with high density of TAMs with HR= 1.504(1.200, 1.884)/ 2.228(1.716, 2.892) respectively. And subgroup analysis of location and biomarker in OS and DFS group showed prognosis was associated with TAMs distribution and biomarker selection. Besides, TAMs high infiltration was significantly related to age, size, histologic grade, ER/PR status, basal phenotype and vascular invasion.

Conclusion: High density of TAMs was associated with poor survival rates of breast cancer. TAMs in stroma are associated with worse outcome than that in nest and using CD68 as a biomarker for TAMs to evaluate the risk is better than CD163 or CD206 alone. Moreover, high infiltration of TAMs was significantly associated with negative hormone receptor status and malignant phenotype. TAMs infiltration can serve as a novel prognostic factor in breast cancer patients.

Citing Articles

Tumor Microenvironment Modulation by Tumor-Associated Macrophages: Implications for Neoadjuvant Chemotherapy Response in Breast Cancer.

Oner G, Praet M, Stoop H, Devi G, Canturk N, Altintas S Breast Cancer (Dove Med Press). 2025; 17:211-224.

PMID: 40008212 PMC: 11853881. DOI: 10.2147/BCTT.S493085.

Drug Treatment Direction Based on the Molecular Mechanism of Breast Cancer Brain Metastasis.

Zhang Y, Shang H, Zhang J, Jiang Y, Li J, Xiong H Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006075 PMC: 11859690. DOI: 10.3390/ph18020262.

From silent partners to potential therapeutic targets: macrophages in colorectal cancer.

Khizar H, Ali K, Wang J Cancer Immunol Immunother. 2025; 74(4):121.

PMID: 39998578 PMC: 11861851. DOI: 10.1007/s00262-025-03965-w.

Recent advances in the role of high-salt diet in anti- and pro-cancer progression.

Tang S, Xu J, Wan P, Jin S, Zhang Y, Xun L Front Immunol. 2025; 16:1542157.

PMID: 39944693 PMC: 11814453. DOI: 10.3389/fimmu.2025.1542157.

The analysis of gene co-expression network and immune infiltration revealed biomarkers between triple-negative and non-triple negative breast cancer.

Yi Y, Zhong Y, Xie L, Lu S, Zhang Y Front Genet. 2025; 15():1505011.

PMID: 39834541 PMC: 11743633. DOI: 10.3389/fgene.2024.1505011.

References

Sousa S, Brion R, Lintunen M, Kronqvist P, Sandholm J, Monkkonen J . Human breast cancer cells educate macrophages toward the M2 activation status. Breast Cancer Res. 2015; 17:101. PMC: 4531540. DOI: 10.1186/s13058-015-0621-0. View

Hollmen M, Roudnicky F, Karaman S, Detmar M . Characterization of macrophage--cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer. Sci Rep. 2015; 5:9188. PMC: 4361875. DOI: 10.1038/srep09188. View

Zhang Q, Liu L, Gong C, Shi H, Zeng Y, Wang X . Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature. PLoS One. 2013; 7(12):e50946. PMC: 3532403. DOI: 10.1371/journal.pone.0050946. View

Yuan Z, Luo R, Peng R, Wang S, Xue C . High infiltration of tumor-associated macrophages in triple-negative breast cancer is associated with a higher risk of distant metastasis. Onco Targets Ther. 2014; 7:1475-80. PMC: 4149399. DOI: 10.2147/OTT.S61838. View

Biswas S, Mantovani A . Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol. 2010; 11(10):889-96. DOI: 10.1038/ni.1937. View

Su S, Liu Q, Chen J, Chen J, Chen F, He C . A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis. Cancer Cell. 2014; 25(5):605-20. DOI: 10.1016/j.ccr.2014.03.021. View

Biswas S, Allavena P, Mantovani A . Tumor-associated macrophages: functional diversity, clinical significance, and open questions. Semin Immunopathol. 2013; 35(5):585-600. DOI: 10.1007/s00281-013-0367-7. View

Grivennikov S, Greten F, Karin M . Immunity, inflammation, and cancer. Cell. 2010; 140(6):883-99. PMC: 2866629. DOI: 10.1016/j.cell.2010.01.025. View

Schreiber R, Old L, Smyth M . Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science. 2011; 331(6024):1565-70. DOI: 10.1126/science.1203486. View

10.

Mantovani A, Germano G, Marchesi F, Locatelli M, Biswas S . Cancer-promoting tumor-associated macrophages: new vistas and open questions. Eur J Immunol. 2011; 41(9):2522-5. DOI: 10.1002/eji.201141894. View

11.

Zhang Y, Cheng S, Zhang M, Zhen L, Pang D, Zhang Q . High-infiltration of tumor-associated macrophages predicts unfavorable clinical outcome for node-negative breast cancer. PLoS One. 2013; 8(9):e76147. PMC: 3786995. DOI: 10.1371/journal.pone.0076147. View

12.

Leek R, Lewis C, Whitehouse R, Greenall M, Clarke J, Harris A . Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res. 1996; 56(20):4625-9. View

13.

Campbell M, Wolf D, Mukhtar R, Tandon V, Yau C, Au A . The prognostic implications of macrophages expressing proliferating cell nuclear antigen in breast cancer depend on immune context. PLoS One. 2013; 8(10):e79114. PMC: 3812150. DOI: 10.1371/journal.pone.0079114. View

14.

Gwak J, Jang M, Kim D, Seo A, Park S . Prognostic value of tumor-associated macrophages according to histologic locations and hormone receptor status in breast cancer. PLoS One. 2015; 10(4):e0125728. PMC: 4401667. DOI: 10.1371/journal.pone.0125728. View

15.

Tiainen S, Tumelius R, Rilla K, Hamalainen K, Tammi M, Tammi R . High numbers of macrophages, especially M2-like (CD163-positive), correlate with hyaluronan accumulation and poor outcome in breast cancer. Histopathology. 2014; 66(6):873-83. DOI: 10.1111/his.12607. View

16.

Yang J, Li X, Liu X, Liu Y . The role of tumor-associated macrophages in breast carcinoma invasion and metastasis. Int J Clin Exp Pathol. 2015; 8(6):6656-64. PMC: 4525881. View

17.

Buldakov M, Zavyalova M, Krakhmal N, Telegina N, Vtorushin S, Mitrofanova I . CD68+, but not stabilin-1+ tumor associated macrophages in gaps of ductal tumor structures negatively correlate with the lymphatic metastasis in human breast cancer. Immunobiology. 2015; 222(1):31-38. DOI: 10.1016/j.imbio.2015.09.011. View

18.

Sica A, Invernizzi P, Mantovani A . Macrophage plasticity and polarization in liver homeostasis and pathology. Hepatology. 2013; 59(5):2034-42. DOI: 10.1002/hep.26754. View

19.

Zheng G, Ge M, Qiu G, Shu Q, Xu J . Mesenchymal Stromal Cells Affect Disease Outcomes via Macrophage Polarization. Stem Cells Int. 2015; 2015:989473. PMC: 4518189. DOI: 10.1155/2015/989473. View

20.

Singla R, Wang J, Singla D . Regulation of Notch 1 signaling in THP-1 cells enhances M2 macrophage differentiation. Am J Physiol Heart Circ Physiol. 2014; 307(11):H1634-42. PMC: 4255013. DOI: 10.1152/ajpheart.00896.2013. View